SOFTWARE USE AGREEMENT FOR TRES (T-CELL RESILIENCE).
The Tres (T-cell Resilience) Software, proprietary to the National Cancer Institute (NCI), Cancer Data Science Laboratory, aims to help biologists to study the gene markers of T-cell resilience (i.e., The ability of T cells to resist immune suppressive tumor microenvironment), using single-cell transcriptomic data.

Software User agrees to:

1, Use the Tres Software for non-profit, research purposes only. Any other use, including any use by a for-profit entity, requires a separate trial or complete license from the NCI by email Dr. Peng Jiang (peng.jiang@nih.gov) and Kevin Chang (changke@mail.nih.gov);
2, Maintain possession and control of the software and not to distribute the Tres Software to any third-parties (i.e. non-registered user);
3, Acknowledge the laboratory of Dr. Peng Jiang in the NCI Cancer Data Science Laboratory as the source of the Tres Software in all oral and written public disclosures and publications; and
4, Use the Tres Software in accordance with all applicable laws, rules and regulations, and policies.
NCI MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF THE SOFTWARE WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER PROPRIETARY RIGHTS. Unless prohibited by law, Software User assumes all liability for claims for damages against it by third parties which may arise from its use of the software.
